Flywheel Appoints Imad B. Nijim As Chief Operating Officer

MINNEAPOLIS, Sept. 30, 2015 /PRNewswire/ -- Flywheel Exchange, LLC, the scientific data management software company, announces the appointment of Imad B. Nijim as its Chief Operating Officer.

Flywheel Logo
"I am pleased to welcome Imad Nijim as part of our executive leadership team." Troy Kopischke, Chief Executive Officer, stated. "Imad brings the skills we need to deliver on our promise to accelerate research and discovery into the sharable age."

Flywheel is the scientist's destination for data management, preservation of analysis, and scientific collaboration. Scientists and researchers around the world are facing the challenge of managing the unprecedented amount of data generated on a daily basis.

"Scientific transparency and reproducibility is a fundamental tenant of good science." Nijim said.  "I am excited to be part of the team building the platform to enable researchers around the world to manage their content and share their findings."

Before joining Flywheel, Imad Nijim held executive and senior management positions at Acuo Technologies and Lexmark Healthcare. There he was instrumental in delivering enterprise class medical image archive and interoperability solutions to large integrated care delivery organizations. Mr. Nijim has extensive services and operations experience in healthcare informatics, enterprise imaging, data sharing and interoperability across multiple clinical disciplines. Imad holds a B.A. in Mathematics and an MBA in Healthcare Management.

About Flywheel, LLC
Flywheel is a scientific data management system that makes data accessible, shareable, and reproducible. A young and innovative company, Flywheel simplifies the capture, organization, and analysis of data while enabling scalable, effective data sharing between scientific research groups worldwide. This will empower scientists to do great work together by allowing them to concentrate on the science, not the IT. For more information, visit

Logo -

To view the original version on PR Newswire, visit:

SOURCE Flywheel Exchange, LLC

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

While the biotech IPO market booms, it can look like going public is easy. But the right strategy, syndicate and aftermarket are still important.

Gene therapy pioneer Jim Wilson and the University of Pennsylvania are teaming up with Regeneron to help deliver its COVID antibody intransally.

Forty percent of PK deficiency patients on mitapivat had hemoglobalin responses, compared to 0% in the placebo group.